Patient-reported daily functioning after SARS-CoV-2 vaccinations in autoimmune neuromuscular diseases.

ABSTRACT:

Background and purpose

There are concerns for safety regarding SARS-CoV-2 vaccines for patients with autoimmune neuromuscular disease. We compared daily functioning using disease-specific patient-reported outcome measures (PROMs) before and after SARS-CoV-2 vaccinations.

Methods

In this substudy of a prospective observational cohort study (Target-to-B!), patients with myasthenia gravis (MG), chronic inflammatory demyelinating polyneuropathy (CIDP), multifocal motor neuropathy (MMN), and idiopathic inflammatory myopathy (IIM) vaccinated against SARS-CoV-2 were included. Surveys of daily functioning (Myasthenia Gravis Activities of Daily Living, Inflammatory Rasch-Built Overall Disability Scale, Multifocal Motor Neuropathy Rasch-Built Overall Disability Scale, and Health Asses

SUBMITTER: van Dam KPJ 

PROVIDER: S-EPMC11555150 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature